|
Reauthorization of the Medical Device User Fee and Modernization Act |
|
|
HEARING
Reauthorization of the Medical Device User Fee and Modernization Act
Subcommittee on Health
Wednesday, May 16, 2007, 10:00 a.m.
2322 Rayburn House Office Building
Hearing Webcast
(Any use of this recording is subject to Rule XI, 4 of the House of Representatives. See text of Rule XI, 4 as posted by the House Committee on Rules.)
Connect to the Archived Audio Webcast of this Hearing (56 kbps) or Download
Witness List & Prepared Testimony (pdf files)
| Panel I |
|
Jeffrey Shuren, M.D., J.D.
Assistant Commissioner for Policy
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857 |
|
Accompanied by:
Daniel G. Schultz, M.D.
Director
Center for Devices and Radiological Health
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857 |
|
| Panel II |
|
Paul LaViolette, M.B.A.
Chief Operating Officer
Boston Scientific Corporation
One Boston Scientific Place
Natick, MA 01760-1537
|
Diana Zuckerman, Ph.D.
President
National Research Center for Women & Families
1701 K Street, NW, Suite 700
Washington, DC 20006 |
Mr. Kelvyn Cullimore, Jr.
MDMA Secretary
President and CEO
Dynatronics Corporation
7030 Park Centre Drive
Salt Lake City, UT 84121 |
Mr. Steven A. Grossman
Executive Director
The FDA Alliance
PO Box 4305
Silver Spring, MD 20914-4305 |
Ms. Diane E. Dorman
Vice President for Public Policy
National Organization for Rare Disorders (NORD)
1050 17th Street, NW, Suite 600
Washington DC 20036 |
|
Hearing Transcript
Not available at this time. The printed hearing should be available within 90-120 days of the conclusion of the hearing. When available, the text of the printed hearing may be viewed at the U.S. Government Printing Office Web site.
|
|
Hearings 
